The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Document
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 22496
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” thefederalregister.org (May 15, 2018), https://thefederalregister.org/documents/2018-10337/pediatric-oncology-subcommittee-of-the-oncologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-do.